GRP
VKTX icon

Global Retirement Partners’s Viking Therapeutics VKTX Stock Holding History

Global Retirement Partners’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.9K Buy
+1,714
New +$55.4K ﹤0.01% 2327
2025
Q4 		$85.1K Sell
2,418
-15
-0.6% -$531 ﹤0.01% 2013
2025
Q3 		$63.9K Buy
2,433
+1,083
+80% +$32.3K ﹤0.01% 1763
2025
Q2 		$35.8K Buy
+1,350
New +$35.5K ﹤0.01% 1959
2024
Q4 		$178K Sell
4,422
-1,092
-20% -$62.3K 0.01% 1014
2024
Q3 		$349K Sell
5,514
-123
-2% -$7.22K 0.01% 741
2024
Q2 		$299K Buy
5,637
+4,622
+455% +$303K 0.01% 745
2024
Q1 		$83.2K Buy
1,015
+565
+126% +$25.1K ﹤0.01% 1163
2023
Q4 		$9.57K Sell
450
-50
-10% -$654 ﹤0.01% 2087
2023
Q3 		$5.37K Buy
+500
New +$7.15K ﹤0.01% 2164
2022
Q3 		– Sell
-14
Closed – – 3004
2022
Q2 		$0 Hold
14
– – ﹤0.01% 2900
2022
Q1 		$0 Buy
+14
New +$50 ﹤0.01% 2797

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Global Retirement Partners's VKTX Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 1,714 shares worth $66.9K. The stake represents ﹤0.01% of the portfolio and ranks #2327 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in VKTX as recently as Q4 2025.

Global Retirement Partners first reported a position in VKTX in Q1 2022 and has held it in 12 quarters since. The position peaked at $349K in Q3 2024. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Global Retirement Partners held 1,714 shares of Viking Therapeutics worth $66.9K as of Q2 2026.
  • Viking Therapeutics was a new Global Retirement Partners position in Q2 2026.
  • Viking Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #2327 holding.
  • Global Retirement Partners first reported a position in Viking Therapeutics in Q1 2022 and has held it in 12 quarters since.
  • Global Retirement Partners's Viking Therapeutics position peaked at $349K in Q3 2024.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.